Your trusted source for investing success

Tag: matrix

Drilling Extends High Grade Nickel-Copper Sulphides at Cathedrals Prospect

St George Mining (ASX: SGQ) (‘St George Mining’ or ‘the Company’) is pleased to announce that further massive nickel-copper sulphides have been intersected at the Cathedrals Prospect which is currently being drilled at the Mt Alexander Project in Western Australia.

Four new drill holes have been completed at the Cathedrals Prospect,

DRILLING INTERSECTS THICK MINERALISED ULTRAMAFIC CHANNEL AT MT ALEXANDER

Highlights:

Stricklands Prospect:

 MAD49 at the Stricklands Prospect intersects a thick 22m interval of nickel-copper sulphide mineralisation comprising disseminated, matrix and massive sulphides at a shallow depth of 31.8m from surface
 MAD52 intersects 2.97m of matrix and massive sulphides 300m to the east of MAD49 from drill testing outside the modelled

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has presented three abstracts at the American Association for Cancer Research (AACR) Annual Meeting. These abstracts are all focused on pre-clinical research to elucidate the mechanism of action (MOA) of

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will present three abstracts at the American Association of Cancer Research (AACR) Annual Meeting. The abstracts are based on research conducted with DelMar’s lead anti-cancer product candidate, VAL-083 (dianhydrogalactitol), a

Northern Uranium Provides Update

Northern Uranium (TSXV:UNO) has provided an update on its 70 percent owned North West Manitoba project.

As quoted in the press release:
The Company can earn up to an 80% interest in the project from CanAlaska Uranium Ltd (TSXV:CVV).

At the end of 2015 the Company completed four drill holes at its North

DelMar Pharmaceuticals to Participate in Key Opinion Leader Luncheon on Glioblastoma Multiforme Featuring Dr. James Perry, MD

DelMar Pharmaceuticals to Participate in Key Opinion Leader Luncheon on Glioblastoma Multiforme Featuring Dr. James Perry, MD

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, will participate in a Key Opinion Leader forum highlighting the Company’s novel treatment for patients suffering from glioblastoma multiforme (“GBM”). The luncheon forum takes place on Thursday, March 9th at 12:00pm EST at the

Skyharbour Intersects 20.8% U3O8 over 1.5 Metres in First Drill Hole at Maverick Zone and Discovers New High Grade Uranium Lens on Moore Lake Uranium Project; Increases Planned Drill Program from 3,500m to 4,500m

Skyharbour Resources (TSXV:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) is pleased to announce the first drill hole of the 2017 winter exploration program on the Moore Lake Uranium Project (the “Project”) intersected high grade uranium mineralization within the Main Maverick Zone lens. Hole ML-199 returned geochemical assays of 20.8% U3O8 over 1.5 metres from

Otis arranges $5.04-million financing with Agnico Eagle

Otis arranges $5.04-million financing with Agnico Eagle

Agnico Eagle Mines Ltd. has agreed to acquire, by way of private placement, 14.42 million common shares of Otis Gold Corp. (TSXV:OOO) at a price of 35 cents per common share for proceeds of $5,047,000. On closing of the transaction, Agnico will own approximately 9.95 per cent of the issued

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network